Following his arrest for securities fraud, former pharmaceutical executive Martin Shkreli was shocked that Evan Greebel, a Kaye Scholer partner who had advised his company, was also being charged.
Shkreli “expressed shock that Mr. Greebel would be charged” and the pharmaceutical head described the government’s decision to charge Greebel as “just bizarre,” said Greebel’s attorneys at Gibson, Dunn & Crutcher, detailing Shkreli’s statement to authorities.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
